Changes in albumin and antioxidant enzyme mRNA expression in infant rat liver following administration of total parenteral nutrition (TPN) with/without soybean oil emulsion were studied. Infant rats were divided into three groups: group 1ϭoral diet, group 2ϭTPN without fat, and group 3ϭTPN with 20% of calories from soybean oil emulsion. The period of TPN administration was 4 d. Serum aspartate aminotransferase and alanine aminotransferase levels were higher in group 2 than in the other groups, with similar levels seen in the other groups. Albumin, Cu, Zn-superoxide dismutase, and glutaredoxin 1 mRNA expression levels were lower in group 2 than in the other groups, with similar levels seen in the other groups. Catalase mRNA expression was higher in group 1 than in the other groups, with the lowest level seen in group 2. Soybean oil emulsion should be included in TPN regimens to prevent down-regulation of albumin and antioxidant enzyme mRNA expression.
The risk of developing total parenteral nutrition (TPN)-related hepatic dysfunction and steatosis is greater in young infants than in adults. 1) Hepatoprotective management, including the provision of an efficient energy source in an appropriate dosage, is necessary during TPN to promote normal growth in infants. The liver is the main source of serum albumin. 2) In protein-energy malnutrition, not only the serum albumin level but also the hepatic albumin mRNA level is known to be markedly decreased. 3) We have recently developed an infant rat model of hepatic dysfunction and steatosis/cholestasis induced by overdose of fat-free TPN. 4) In the pathogenesis of such non-alcoholic steatohepatitis, oxidative stress/lipid peroxidation and its end products are thought to play a role. 5) Reactive oxygen species (ROS) may induce a stress response in the cells by altering the expression of antioxidant defense systems to rescue the cell. A comprehensive defense system against ROS is known to comprise the well-established superoxide dismutase (SOD)/catalase enzymatic system 3) and the newly described thioredoxin (Trx)/glutathione (GSH) thiol-based antioxidant system. 6) The activity levels of Cu, Zn-superoxide dismutase (CuZn-SOD) and catalase are higher in the liver than in other tissues. 7) CuZn-SOD dismutates two molecules of the superoxide anion to oxygen and hydrogen peroxide, and the hydrogen peroxide is subsequently reduced to water by catalase. In order to maintain the cellular thiol-disulfide redox status under reducing conditions, living cells possess two major systems, the Trx/Trx reductase system and the GSH/glutaredoxin (Grx) system. 6, 8, 9) It is thought that hepatic dysfunction and steatosis is the most common complication encountered in patients receiving long-term TPN, but it is said to express itself as cholestasis in infants. 1, 10) Recently, the hepatoprotective efficacy of 3-component infusion solutions for TPN has been demonstrated using GA-1080 (MIXID ® , a TPN solution containing amino acids, glucose, and soybean oil emulsion) in clinical studies. 11) Using our infant animal model of hepatic dysfunction and steatosis induced by overdose of fat-free TPN, we have demonstrated that metabolic complications such as those related to fat in the liver can be significantly improved by including soybean oil in the TPN regimen. 4, 12) We have also reported that fat-free TPN is associated with large lipid droplets in hepatocytes, while fat-containing TPN is associated with significantly smaller lipid droplets.
12) Furthermore, we have also reported that including fat in the TPN regimen is of great importance in preventing the mRNA down-regulation of cytochrome P450s. 13) Cytochrome P450 isoenzymes such as CYP2E1 are thought to be related to oxidative stress and cell injury. 14) However, to our knowledge, there have been no reports describing the changes in albumin and antioxidant enzyme expression in the liver following the administration of TPN with or without soybean oil emulsion.
Using our infant rat TPN model, the present study was conducted to investigate whether the inclusion of soybean oil in the TPN regimen affects the hepatic mRNA expression of albumin and antioxidant enzymes.
MATERIALS AND METHODS

Animals and Diets
Male Sprague-Dawley rats at 3 weeks of age were obtained from Charles River Japan SLC, Inc. (Kanagawa, Japan). The rats were housed in a room with a 12-h light : dark schedule and allowed free access to water and standard rat diet containing 54.5 starch, 22.4 protein, 5.7 fat, 3.1 fiber, and 6.6 mineral and vitamin mixture (all values given as g/100 g; CRF-1, Oriental Yeast Co., Ltd., Tokyo, Japan 4) Briefly, infant (3-week-old) male Sprague-Dawley rats weighing 60-70 g were randomly allocated to three groups (nϭ6 in each group): group 1 received an oral diet, group 2 received TPN without fat, and group 3 received TPN with 20% of calories from soybean oil emulsion. In this report, group 1 is referred to as the oral diet group and groups 2 and 3 are collectively referred to as the TPN groups. In the TPN groups, after the rats were fasted overnight, a catheter for the infusion of TPN was placed in the jugular vein under general anesthesia with diethyl ether. All TPN regimens were isocaloric (1000 kcal/l) and isonitrogenic. The compositions of the TPN solutions with and without fat are shown in Table 1 . The amount of phosphorus in the fat-containing TPN formulation is greater than that in the fat-free TPN formulation because the fat-containing TPN formulation includes phosphorus derived from the phospholipids in soybean oil and egg lecithin. Otsuka MV injection (Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan) was used to supply vitamins. Infusion was started immediately after cannulation at 3 ml/kg body weight/h for the first 12 h and then increased in a stepwise manner every 12 h to 10, 20, and then 30 ml/kg/h. On the third day, the infusion rate was increased to 40 ml/kg/h (i.e., full-dose TPN) and maintained at that level thereafter. The total experimental period was 4 d, and continuous infusion was maintained with a Terufusion pump (Terumo Co., Tokyo, Japan). An administration rate of 40 ml/kg/h, which was found to induce abnormal changes in blood chemistry values suggestive of cholestasis and hepatic dysfunction in the dose selection study, was used in the present study. The animals were anesthetized with diethyl ether and the abdominal cavity was opened. Blood samples were drawn from the vena cava and the animals were killed by exsanguination, after which the entire liver was rapidly excised. The blood samples were placed in tubes with or without EDTA-Na 2 and were immediately centrifuged. Total RNA was extracted from the liver using the Rneasy ® Mini kit and QIAshredder TM .
Analytical Method
The hematocrit value was measured by centrifugation (10000 rpm) with a Hematocrit KH-120A centrifuge (Kubota, Tokyo, Japan).
Biochemical Examination Serum samples were analyzed for aspartate aminotransferase (AST), alanine aminotransferase (ALT), and albumin using an autoanalyzer (Model 7170, Hitachi Co., Tokyo, Japan). AST and ALT activity levels were measured by the JSCC (Japan Society of Clinical Chemistry) transferable method. The serum albumin concentration was measured by the bromcresol green (BCG) method.
Oligonucleotides The forward and reverse primers and the TaqMan probes were designed using Primer Express software (Applied Biosystems) from the rat mRNA sequence (Table 2) . Each primer and/or probe was homology searched by an NCBI BLAST search to ensure that it was specific for the target mRNA transcript. The primers and TaqMan probes were synthesized by QIAGEN (Tokyo, Japan). The TaqMan probes contained 6-carboxyfluorescein (FAM) at the 5Ј end and 6-carboxytetramethylrhodamine (TAMRA) at the 3Ј end and were designed to hybridize to a sequence located between the PCR primers.
TaqMan RT-PCR Conditions Total hepatic RNA was diluted with 50-mg/ml yeast tRNA to 5 mg/ml. The RT-PCR assay was performed using the ABI PRISM 7700 Sequence Detector system (Applied Biosystems) under the same conditions as in our previous studies.
13 ) The relative expression of each mRNA was calculated by the ᭝Ct method (where ᭝Ct is the value obtained by subtracting the Ct value of b-actin mRNA from the Ct value of the target mRNA), as employed in previous studies. [15] [16] [17] Specifically, the amount of target mRNA relative to b-actin mRNA is expressed as 2
Ϫ(᭝Ct)
. Data are expressed as the ratio of target mRNA to b-actin mRNA.
Statistical Analysis Studies were conducted in duplicate and data are shown as meanϮS.D. of 6 rats. The statistical significance of differences between mean values was analyzed by Tukey's test.
RESULTS AND DISCUSSION
The infant rats were divided into three groups (nϭ6 in each group): group 1 received an oral diet, group 2 received TPN without fat, and group 3 received TPN with 20% of calories from soybean oil emulsion (Table 1) . None of the animals in groups 2 and 3 showed any adverse effects such as debilitation or reduced mobility following the surgical procedure, as assessed by gross examination, during the period of TPN administration.
The results for body weight, liver weight, and hematocrit values in infant rats that received TPN for 4 d are shown in Table 3 . The body weight in group 1 (oral diet) was higher than that in the other groups (fat-free and fat-containing TPN), but the liver weight in group 1 was lower than that in the other groups. There were significant differences between the TPN groups, and the body weight was higher and the liver weight was lower in group 3 (fat-containing TPN) than in group 2 (fat-free TPN). These results indicate that growth delay and hepatomegaly were induced in rats that received fat-free TPN as compared with rats that were fed an oral diet. The administration of fat-containing TPN significantly mitigated the adverse effects associated with fat-free TPN. The hematocrit value, as an index of anemia, was higher in group 1 than in groups 2 and 3, but there was no significant differ- ence between the TPN groups. Both the serum AST and ALT levels in infant rats that received TPN for 4 d were significantly higher (pϽ0.001) in group 2 than in the other groups, but there were no significant differences between groups 1 and 3 ( Fig. 1) . Based on the results of biochemical examination, an overdose of fatfree TPN induced severe liver damage, as we have reported previously. 4) It is notable that the addition of fat emulsion to the TPN regimen completely prevented the development of hepatic dysfunction in the infant rats. We recently found that the infusion of excessive glucose in a fat-free TPN model in rats resulted in increased hepatic lipogenesis 12) and decreased hepatic lipolysis (unpublished observations). The mRNA level of cytosolic glucokinase, a glycolytic enzyme, was decreased, but that of acetyl-coenzyme A carboxylase-1, which is pivotal in lipid synthesis, was markedly increased. 12) Therefore, the hepatic dysfunction observed in this animal model may result from the accumulation of fat and the accompanying oxidative stress in the organ.
The serum albumin concentration in group 1 was significantly higher (pϽ0.01) than that in the other groups, but a) Primers and probes were sequences employed in our previous study.
13)
The positions of the primers and probes were counted from the position of the initiation codon. CuZn-SOD, Cu, Zn-superoxide dismutase; Grx1, glutaredoxin 1; Grx2, glutaredoxin 2; Trx1, thioredoxin 1; Trx2, thioredoxin 2.
there was no significant difference between groups 2 and 3 ( Fig. 2) . This finding may have reflected dilution of the blood following the administration of TPN at an excessive dosage of 40 ml/kg/h because the hematocrit values in both TPN groups were lower than that in the oral diet group (Fig. 2 , Table 3 ). On the other hand, the level of hepatic albumin mRNA expression in group 2 (fat-free TPN) decreased to 30-40% that in groups 1 and 3 ( pϽ0.001 and pϽ0.01, respectively), although there was no significant difference between groups 1 and 3, indicating that the expression of albumin mRNA was maintained by the inclusion of fat in the TPN regimen (Fig. 3) . Since the half-life of albumin is 17 to 19 d 18) and about 4% of the exchangeable pool is degraded per day, 19) the down-regulation of hepatic albumin mRNA expression after the administration of fat-free TPN for only 4 d was not reflected in the serum albumin concentration. However, the long-term administration of TPN with carbohydrates as the sole source of calories may induce hepatic dysfunction and a reduction in serum albumin, which can be fatal to neonates or infants who do not receive oral feeding for a prolonged period.
It is interesting to consider the expression of antioxidant defense systems in the liver with steatosis/cholestasis induced by overdose of fat-free TPN. First, the mRNA expression levels of cytosolic CuZn-SOD 20) and microsomal catalase 21) in the three groups were determined and compared. The CuZn-SOD mRNA expression level in group 2 (fat-free TPN) was approximately one-half that in group 1 (oral diet), but the addition of fat to the TPN regimen restored mRNA expression to the same level as in group 1 (Fig. 4) . The catalase mRNA expression level in group 2 fell to 22% that in group 1, but the level in group 3 was maintained at 74% that in group 1 (Fig. 4) . Furthermore, we also investigated the Trx and Grx systems. Two types of Trx have been described in mammals, one predominantly cytosolic (Trx1) 22) and the other mitochondrial (Trx2). 23) Two different isoenzymes of mammalian Grx have also been described, one a classical cytosolic enzyme (Grx1) and the other a mitochondrial protein (Grx2), with alternative splice variants. 24, 25) The administration of fat-free TPN led to a reduction in only hepatic Grx1 mRNA expression to less than one-half that in the other groups (pϽ0.001), although the level in group 3 was not significantly different from that in group 1 (Fig. 5) . On the other hand, the mRNA expression levels of Grx2, Trx1, and Trx2 did not differ significantly between the three groups (Fig. 5) . Although the MIXID ® formulation 11) used in this study includes a small amount of vitamin E (a general antioxidant) originating from soybean oil, the antioxidant effect of the inclusion of vitamin E was judged to be minimal (data not shown).
We recently reported that an increase in the serum bilirubin concentration, reflecting the development of hepatic dysfunction such as cholestasis, may occur due to changes in transporters such as Mrp1 and Mrp2 in the liver of infant rats that received an overdose of fat-free TPN. 26) Furthermore, in the present study, mRNA down-regulation of antioxidant enzymes such as CuZn-SOD, catalase, and Grx1 was observed in the liver of infant rats that received an overdose of fat-free TPN. We therefore feel that the observed hepatic dysfunction such as cholestasis and steatosis may be due to a complex mechanism involving changes in many targets such as transporters and antioxidant enzymes.
The present study has shown that the hepatic steatosis observed in infant rats that received an overdose of fat-free TPN was associated with the mRNA down-regulation of albumin and antioxidant enzymes such as CuZn-SOD, catalase, and Grx1. Specifically, defects in the antioxidant defense systems may result in the production of ROS, the promotion of oxidative stress, and thus functional damage in the infant liver. The addition of soybean oil to the TPN regimen showed a dramatic effect in preventing the adverse reactions observed in infant rats that received TPN without fat. The results of the present study indicate the importance of using an appropriate TPN formulation including fat emulsion in order to avoid hepatic dysfunction and growth delay in pediatric patients. 
